During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Ferdinand K. Hui, MD
Advertisement
Articles by Ferdinand K. Hui, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants breakthrough therapy designation to Nacuity’s NPI-001 for retinitis pigmentosa
2
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA
3
AAO 2025: Don’t miss presentations from our Editorial Advisory Board members
4
Q&A: Peter Kaiser explains the ongoing SOL-1 and SOL-R study of OTX-TKI
5
.png "Optometry Times"){kind=logo}
